Evidence map›Paper›PMID 39552538›Full record

ArticleAnnals of neurology2025

Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease.

Michael S Stringer, Gordon W Blair, Anna Kopczak, Danielle Kerkhofs, Michael J Thrippleton, Francesca M Chappell, Susana Muñoz Maniega, Rosalind Brown, Kirsten Shuler, Iona Hamilton and 15 more

Abstract readMulticenter Study
In one paragraph

Article in Annals of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Pericyte KNature cardiovascular research · 2026
    Article
  3. Article
  4. Article
  5. MRI markers of cerebrospinal fluid dynamics predict dementia and mediate the impact of cardiovascular risk.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  6. Article
  7. Imaging brain fluid dynamics and waste clearance involving perivascular spaces in cerebral small vessel disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Michael S StringerBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-3811-4439
Gordon W BlairBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Anna KopczakInstitute for Stroke and Dementia Research (ISD), University Hospital, Munich, Germany.
Danielle KerkhofsDepartment of Neurology, CARIM School for cardiovascular diseases, Maastricht University Medical Center, Maastricht, the Netherlands.
Michael J ThrippletonBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Francesca M ChappellBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Susana Muñoz ManiegaBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Rosalind BrownBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Kirsten ShulerBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Iona HamiltonBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Daniela Jaime GarciaBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Fergus N DoubalBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Una ClancyBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Eleni SakkaBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Tetiana PoliakovaBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Esther JanssenBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
Marco DueringInstitute for Stroke and Dementia Research (ISD), University Hospital, Munich, Germany.
Michael IngrischDepartment of Radiology, University Hospital, Munich, Germany.
Julie StaalsDepartment of Neurology, CARIM School for cardiovascular diseases, Maastricht University Medical Center, Maastricht, the Netherlands.
Walter H BackesDepartment of Radiology & Nuclear Medicine, Maastricht University Medical Center, Schools for Mental Health & Neuroscience and Cardiovascular Disease, Maastricht, the Netherlands.ORCID 0000-0001-7905-0681
Robert van OostenbruggeDepartment of Neurology, CARIM School for cardiovascular diseases, Maastricht University Medical Center, Maastricht, the Netherlands.
Geert Jan BiesselsDepartment of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, Netherlands.
Martin DichgansInstitute for Stroke and Dementia Research (ISD), University Hospital, Munich, Germany.
Joanna M WardlawBrain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-9812-6642
SVDs@target consortium

Funding

Arx Associated Transcriptional Networks in Neocortical DevelopmentR01NS100007 · NINDS · CEDARS-SINAI MEDICAL CENTER · PI GOLDEN, JEFFREY A · 2018 to 2021
$1.5M
Arx Associated Transcriptional Networks in Neocortical DevelopmentR56NS100007 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLDEN, JEFFREY A · 2017 to 2017
$313k
Age UKAlzheimer's Society 252(AS-PG-14-033)Biotechnology and Biological Sciences Research Council BB/W008793/1Chief Scientist Office CAF/18/08, UCDeutsche Forschungsgemeinschaft EXC 2145 SyNergy-ID 390857198Deutsche Forschungsgemeinschaft INST 409/193-1 FUGGEdinburgh and Lothians Health FoundationFondation Leducq 16 CVD 05Horizon 2020 Framework Programme 666881Mrs Gladys Row Fogo Charitable TrustNHS Lothian Research and Development OfficeNHS Research ScotlandScottish Funding Council through the SINAPSE collaborationStiftung zur Erforschung der Vaskulären DemenzStroke Association Postdoctoral Fellowship, Garfield Weston Foundation Senior Clinical Lecture, Princess Margaret Research Development Fellowship SA LECT 2015/04Stroke Association Postdoctoral Fellowship, Garfield Weston Foundation Senior Clinical Lecture, Princess Margaret Research Development Fellowship SA PDF 23\100007Stroke Association Postdoctoral Fellowship, Garfield Weston Foundation Senior Clinical Lecture, Princess Margaret Research Development Fellowship TSALECT2015/04UK Dementia Research InstituteWellcome TrustWellcome Trust 224912/Z/21/ZWellcome Trust Translational Neuroscience PhD programme at the University of Edinburgh, DJG
6 · The paper itself

Abstract

objectiveCerebral small vessel diseases (SVDs) are associated with cerebrovascular dysfunction, such as increased blood-brain barrier leakage (permeability surface area product), vascular pulsatility, and decreased cerebrovascular reactivity (CVR). No studies assessed all 3 functions concurrently. We assessed 3 key vascular functions in sporadic and genetic SVD to determine associations with SVD severity, subtype, and interrelations.

methodsIn this prospective, cross-sectional, multicenter INVESTIGATE-SVDs study, we acquired brain magnetic resonance imaging in patients with sporadic SVD/cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), including structural, quantitative microstructural, permeability surface area product, blood plasma volume fraction, vascular pulsatility, and CVR (in response to CO

resultsWe recruited 77 patients (45 sporadic/32 CADASIL) at 3 sites. In adjusted analyses, patients with worse WMH had lower CVR (B = -1.78, 95% CI -3.30, -0.27) and blood plasma volume fraction (B = -0.594, 95% CI -0.987, -0.202). CVR was worse in WMH than normal-appearing white matter (eg, CVR: B = -0.048, 95% CI -0.079, -0.017). Adjusting for WMH severity, SVD subtype had minimal influence on vascular function (eg, CVR in CADASIL vs sporadic: B = 0.0169, 95% CI -0.0247, 0.0584). Different vascular function mechanisms were not generally interrelated (eg, permeability surface area product~CVR: B = -0.85, 95% CI -4.72, 3.02). Principal component analyses identified WMH volume/quantitative microstructural metrics explained most variance in CADASIL and arterial pulsatility in sporadic SVD, but similar main variance sources.

interpretationVascular function was worse with higher WMH, and in WMH than normal-appearing white matter. Sporadic SVD-CADASIL differences largely reflect disease severity. Limited vascular function interrelations may suggest disease stage-specific differences. ANN NEUROL 2025;97:483-498.

Indexed as

CADASILCerebral Small Vessel DiseasesCerebrovascular CirculationAdultAgedBlood-Brain BarrierBrainCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedProspective StudiesWhite Matter

Identifiers

PMID39552538
PMCPMC11831873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.